This is a preview of subscription content, log in via an institution to check access.
Reference
Koltermann V, et al. Cost-benefit impact of free asthma medication provision for the pediatric population. Respiratory Medicine 164: 105915, Apr 2020. Available from: URL: http://doi.org/10.1016/j.rmed.2020.105915
Rights and permissions
About this article
Cite this article
Free asthma medications reduce hospitalisations and costs in Brazil. PharmacoEcon Outcomes News 851, 21 (2020). https://doi.org/10.1007/s40274-020-6744-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6744-2